RhumbLine Advisers’s Alamar Biosciences ALMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$567K Buy
16,638
+2,487
+18% +$73.3K ﹤0.01% 2650
2026
Q2
$383K Buy
+14,151
New +$320K ﹤0.01% 2922

Other funds holding ALMR

RhumbLine Advisers's ALMR Position: Q3 2026 in Review

RhumbLine Advisers increased its Alamar Biosciences (ALMR) stake by 18% in Q3 2026, buying an estimated $73.3K and bringing the position to 16,638 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

RhumbLine Advisers first reported a position in ALMR in Q2 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold ALMR as of Q3 2026.

  • RhumbLine Advisers held 16,638 shares of Alamar Biosciences worth $567K as of Q3 2026.
  • RhumbLine Advisers bought 2,487 Alamar Biosciences shares in Q3 2026, an estimated $73.3K.
  • Alamar Biosciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2650 holding.
  • RhumbLine Advisers first reported a position in Alamar Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Alamar Biosciences as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.